文献速递消化系统肿瘤

PTHrP 驱动胰腺癌生长转移并提示新治疗靶点

PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability.
PubMed 文献 · Cancer Discov · 2021-02-15

研究报道甲状旁腺激素相关蛋白(PTHrP,由 PTHLH 编码)在胰腺癌患者中常随 KRAS 扩增子一同扩增,其上调驱动小鼠原发与转移肿瘤生长,并在胰腺导管腺癌转移灶中高度富集。遗传或药物手段去除 PTHrP 可显著降低肿瘤负荷、消除转移并改善总生存,部分经减少上皮间质转化介导,骨桥蛋白(Spp1)为下游效应分子。

要点

  • PTHLH 常随 KRAS 扩增子扩增,PTHrP 在胰腺导管腺癌转移灶中高度富集。
  • 遗传或药物去除 PTHrP 可降低肿瘤负荷、消除转移并改善小鼠总生存。
  • 效应部分经减少上皮间质转化实现,Spp1(骨桥蛋白)为下游效应分子。

核心结论

  • PTHrP 是胰腺癌疾病进展的驱动因素,并作为新的治疗脆弱点出现。

研究设计与样本

  • 临床前小鼠研究,结合胰腺癌患者基因组扩增分析与功能实验。

主要发现

  • PTHrP 上调驱动小鼠原发与转移肿瘤生长。
  • PTHrP 在胰腺导管腺癌转移灶中高度富集。
  • 遗传或药物去除 PTHrP 显著降低肿瘤负荷、消除转移并改善总生存。
  • 上述效应部分通过减少上皮间质转化介导。
  • Spp1 编码的骨桥蛋白被揭示为 PTHrP 的下游效应分子。

临床怎么用

  • 提示抑制 PTHrP 活性可能成为减少原发肿瘤生长、预防转移并延长生存的候选策略(尚属临床前)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pancreatic cancer metastasis is a leading cause of cancer-related deaths, yet very little is understood regarding the underlying biology. As a result, targeted therapies to inhibit metastasis are lacking. Here, we report that the parathyroid hormone-related protein (PTHrP encoded by PTHLH) is frequently amplified as part of the KRAS amplicon in patients with pancreatic cancer. PTHrP upregulation drives the growth of both primary and metastatic tumors in mice and is highly enriched in pancreatic ductal adenocarcinoma metastases. Loss of PTHrP-either genetically or pharmacologically-dramatically reduces tumor burden, eliminates metastasis, and enhances overall survival. These effects are mediated in part through a reduction in epithelial-to-mesenchymal transition, which reduces the ability of tumor cells to initiate metastatic cascade. Spp1, which encodes osteopontin, is revealed to be a downstream effector of PTHrP. Our results establish a new paradigm in pancreatic cancer whereby PTHrP is a driver of disease progression and emerges as a novel therapeutic vulnerability. SIGNIFICANCE: Pancreatic cancer often presents with metastases, yet no strategies exist to pharmacologically inhibit this process. Herein, we establish the oncogenic and prometastatic roles of PTHLH, a novel amplified gene in pancreatic ductal adenocarcinoma. We demonstrate that blocking PTHrP activity reduces primary tumor growth, prevents metastasis, and prolongs survival in mice.This article is highlighted in the In This Issue feature, p. 1601.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Pitarresi JR, Norgard RJ, Chiarella AM, et al. PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability. Cancer Discov. 2021. PMID: 33589425. doi:10.1158/2159-8290.CD-20-1098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。